Skip to main navigation Skip to search Skip to main content

AML-392 Treatment of Blastic Plasmacytoid Dendritic Cell Neoplasm in Pediatric Patients With Tagraxofusp, a CD123-Targeted Therapy

  • Naveen Pemmaraju
  • , Branko Cuglievan
  • , Joseph Lasky
  • , Albert Kheradpour
  • , Nobuko Hijiya
  • , Anthony S. Stein
  • , Soheil Meshinchi
  • , Craig Mullen
  • , Emanuele Angelucci
  • , Luciana Vinti
  • , Tariq I. Mughal
  • , Anna Pawlowska

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    Pages (from-to)S244-S245
    JournalClinical Lymphoma, Myeloma and Leukemia
    Volume22
    Issue numbersuppl 2
    DOIs
    StatePublished - Oct 2022

    ASJC Scopus Subject Areas

    • Hematology
    • Oncology
    • Cancer Research

    Keywords

    • AML
    • BPDCN
    • CD123
    • TAG
    • pediatric
    • plasmacytoid dendritic cell
    • tagraxofusp
    • targeted therapy

    Cite this